Pharmacist Outreach and SGLT2 Inhibitor Uptake in Patients With Diabetes and Chronic Kidney Disease

1

Chronic kidney disease (CKD) affects nearly 15% of adults in the US and significantly contributes to morbidity and healthcare costs.
2

SGLT2 inhibitors have shown significant benefits in CKD management, including reduced progression to kidney failure and improved survival.
3

The study aimed to assess whether pharmacists' outreach could increase the initiation of SGLT2 inhibitors among eligible patients.
4

A multicenter quality improvement initiative was conducted across 8 Veterans Affairs health systems to evaluate the intervention's effectiveness.
5

The outreach involved mailing letters and scheduling calls with pharmacists to discuss SGLT2 inhibitors with eligible patients.

1